Vitality Watch

Dossier clinicaltrials trial early 10-nov-2026
Small or early-phase human trial or pilot study

Systems Investigation of Vaccine Responses in Aging and Frailty

Key claim: A systems biology study will compare the immunologic, transcriptomic, and metabolomic response signatures of two standard senior influenza vaccines (Fluad and Fluzone High-Dose) in adults aged 65 and older.

Abstract

This study will compare the immune response signatures (including immunologic, transcriptomic and metabolomic) of the two influenza vaccines approved for use in adults age 65 and over (Fluad and Fluzone High-Dose).

Why this matters

A systems biology study will compare the immunologic, transcriptomic, and metabolomic response signatures of two standard senior influenza vaccines (Fluad and Fluzone High-Dose) in adults aged 65 and older.

Source

Link

Briefing card

Systems Investigation of Vaccine Responses in Aging and Frailty
Stage: trial early · clinicaltrials · 10-nov-2026

A systems biology study will compare the immunologic, transcriptomic, and metabolomic response signatures of two standard senior influenza vaccines (Fluad and Fluzone High-Dose) in adults aged 65 and older.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT05291676

build build 880 · 2bcef25 · 2026-11-18